Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
May 02, 2024 08:03 ET
|
Longeveron
Longeveron to report Q1 2024 financial results on May 14, 2024.
Longeveron to Present at the Planet MicroCap Showcase
April 25, 2024 16:05 ET
|
Longeveron
Longeveron to present at investor conference - Planet MicroCap Showcase - May 1, 2024.
Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering
April 18, 2024 16:05 ET
|
Longeveron
Longeveron raises $11.4 million in gross proceeds from warrent exercise offering and public offering.
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
April 17, 2024 08:00 ET
|
Longeveron
Longeveron raises gross proceeds of ~$6.2 M from exercise of certain existing warrants to purchase an aggregate of 2,399,744 shares of its common stock.
Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
April 15, 2024 08:30 ET
|
Longeveron
Data from Longeveron's CLEAR MIND Phase 2a clinical trial evaluating Lomecel-B in Alzheimer’s Disease has been accepted for two presentations at AAIC.
Longeveron Announces Closing of $5.2 Million Public Offering
April 11, 2024 17:17 ET
|
Longeveron
Longeveron announces closing of previously announced public offering, raising $5.25 million in gross proceeds.
Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals
April 08, 2024 08:30 ET
|
Longeveron
CEO Letter to Shareholders. Update on overall strategy, business objectives, approach to capital allocation, and 2024 key priorities and goals.
Investors with substantial Losses in NASDAQ: LGVN shares should contact the Shareholders Foundation in connection with the Lawsuit against Longeveron Inc.
November 09, 2021 09:20 ET
|
Shareholders Foundation, Inc.
SAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Longeveron Inc. (NASDAQ: LGVN). Investors who...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Longeveron, Boston Beer, Waterdrop, and AppHarvest and Encourages Investors to Contact the Firm
November 02, 2021 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Longeveron, Boston Beer, Waterdrop, and AppHarvest and Encourages Investors to Contact the Firm
October 27, 2021 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...